Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2554962 | 0.91 | GPR119 (1.00) | GPR119CYP2C9 | |
| SCHEMBL12282977 | 0.91 | GPR119 (1.00) | GPR119CYP2C9 | |
| SCHEMBL14634344 | 0.87 | GPR119 (0.71) | GPR119CYP2C9 | |
| SCHEMBL12282715 | 0.85 | GPR119 (0.84) | GPR119CYP2C9 | |
| SCHEMBL14634290 | 0.85 | GPR119 (0.84) | GPR119CYP2C9 | |
| SCHEMBL14634294 | 0.85 | GPR119 (0.84) | GPR119CYP2C9 | |
| SCHEMBL12282718 | 0.83 | GPR119 (0.81) | GPR119 | |
| SCHEMBL14634425 | 0.83 | GPR119 (0.81) | GPR119 | |
| SCHEMBL14634226 | 0.83 | GPR119 (0.81) | GPR119 | |
| SCHEMBL2552149 | 0.83 | GPR119 (0.81) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2556056-A1 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011127051-A1 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-10-13 | — | — | WO | disclosed |